Review article · 2025 · Open access

Machine learning empowered formulation design, optimization and characterization of nanoparticulate drug delivery systems: Current applications, challenges, and future perspectives

Chunyan Shen, Mengyan Zhang, Meiting Lu, Errong Chang, Ziting Gao, Weikang Ban, Qiang Liu, Zhong Zuo, Cuiping Jiang

Acta Pharmaceutica Sinica B, 16(2), 665–685 · Published 10 December 2025 · DOI 10.1016/j.apsb.2025.12.011

Open full textCite this paper

In brief

“Machine learning empowered formulation design, optimization and characterization of nanoparticulate drug delivery systems: Current applications, challenges, and future perspectives” is a 2025 review article by Chunyan Shen and 8 co-authors, published in Acta Pharmaceutica Sinica B. OpenAlex counts 77 citations as of 16 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Acta Pharmaceutica Sinica B.

Citations
77
Most cited in
2026 (77)
Field-weighted impact
3.62
References
217
Authors
9

Abstract

Nanoparticulate drug delivery systems (NDDS) have revolutionized modern medicine by significantly improving drug targeting, bioavailability, and therapeutic efficacy. Despite the clinical success of over 90 approved nanomedicines, the development of NDDS remains challenging due to the complexity of formulation design, optimization, and characterization processes. Artificial intelligence, particularly machine learning (ML), offers powerful data analytics and predictive capabilities that can address these challenges. This review systematically summarizes recent advances in ML applications across various NDDS formulations, including polymeric nanoparticles, lipid nanoparticles, liposomes, solid lipid nanoparticles, nanostructured lipid carriers, nanoemulsions, nanosuspensions, lipid-based hybrid NDDS, self-emulsifying drug delivery systems, niosomes, and nanocrystals. We also summarize how ML algorithms could help predict critical quality attributes of NDDS, such as particle size, shape, surface properties, drug encapsulation efficiency, drug loading efficiency, drug release behavior, and stability. Furthermore, we discuss existing challenges and prospects for the formulation development empowered by ML in NDDS. In conclusion, this review provides a comprehensive overview of the transformative potential of ML in improving the formulation development of nanomedicines, ultimately accelerating their clinical translation.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Shen, C., Zhang, M., Lu, M., Chang, E., Gao, Z., Ban, W., Liu, Q., Zuo, Z., & Jiang, C. (2025). Machine learning empowered formulation design, optimization and characterization of nanoparticulate drug delivery systems: Current applications, challenges, and future perspectives. Acta Pharmaceutica Sinica B, 16(2), 665–685. https://doi.org/10.1016/j.apsb.2025.12.011

MLA 9

Shen, Chunyan, et al. “Machine learning empowered formulation design, optimization and characterization of nanoparticulate drug delivery systems: Current applications, challenges, and future perspectives.” Acta Pharmaceutica Sinica B, vol. 16, no. 2, 2025, pp. 665–685. https://doi.org/10.1016/j.apsb.2025.12.011.

Chicago

Shen, Chunyan, Mengyan Zhang, Meiting Lu, Errong Chang, Ziting Gao, Weikang Ban, Qiang Liu, Zhong Zuo, and Cuiping Jiang. 2025. “Machine learning empowered formulation design, optimization and characterization of nanoparticulate drug delivery systems: Current applications, challenges, and future perspectives.” Acta Pharmaceutica Sinica B 16 (2): 665–685. https://doi.org/10.1016/j.apsb.2025.12.011.

Harvard

Shen, C. et al. (2025) ‘Machine learning empowered formulation design, optimization and characterization of nanoparticulate drug delivery systems: Current applications, challenges, and future perspectives’, Acta Pharmaceutica Sinica B, 16(2), pp. 665–685. doi:10.1016/j.apsb.2025.12.011.

IEEE

C. Shen et al., “Machine learning empowered formulation design, optimization and characterization of nanoparticulate drug delivery systems: Current applications, challenges, and future perspectives,” Acta Pharmaceutica Sinica B, vol. 16, no. 2, pp. 665–685, 2025, doi: 10.1016/j.apsb.2025.12.011.

BibTeX

@article{shen2025machine,
  title     = {{Machine learning empowered formulation design, optimization and characterization of nanoparticulate drug delivery systems: Current applications, challenges, and future perspectives}},
  author    = {Shen, Chunyan and Zhang, Mengyan and Lu, Meiting and Chang, Errong and Gao, Ziting and Ban, Weikang and Liu, Qiang and Zuo, Zhong and Jiang, Cuiping},
  journal   = {Acta Pharmaceutica Sinica B},
  year      = {2025},
  volume    = {16},
  number    = {2},
  pages     = {665--685},
  doi       = {10.1016/j.apsb.2025.12.011},
  url       = {https://doi.org/10.1016/j.apsb.2025.12.011}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery

  • nanoparticle drug delivery
  • machine learning
  • polymeric nanoparticles
  • lipid nanoparticles
  • liposomes
  • solid lipid nanoparticles
  • nanostructured lipid carriers
  • nanoemulsions

Work with this paper

Most-cited papers in Materials Science

All highly cited Materials Science papers

Questions about this paper

How do I cite this paper in APA style?

Shen, C., Zhang, M., Lu, M., Chang, E., Gao, Z., Ban, W., Liu, Q., Zuo, Z., & Jiang, C. (2025). Machine learning empowered formulation design, optimization and characterization of nanoparticulate drug delivery systems: Current applications, challenges, and future perspectives. Acta Pharmaceutica Sinica B, 16(2), 665–685. https://doi.org/10.1016/j.apsb.2025.12.011

How many times has this paper been cited?

77 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Acta Pharmaceutica Sinica B: sign in and open the full text from this page.

Who wrote this paper?

Chunyan Shen, Mengyan Zhang, Meiting Lu, Errong Chang, Ziting Gao, Weikang Ban, Qiang Liu, Zhong Zuo, Cuiping Jiang.

What is the DOI of this paper?

10.1016/j.apsb.2025.12.011, permanently at https://doi.org/10.1016/j.apsb.2025.12.011. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.